Page last updated: 2024-11-13

n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1h-indazole-3-carboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide: a street drug; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102144602
MeSH IDM000608042

Synonyms (8)

Synonym
unii-8fst4iag3n
1863065-99-9
n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1h-indazole-3-carboxamide
8fst4iag3n ,
5-fluoro-ab-pinaca, (+/-)-
1h-indazole-3-carboxamide, n-(1-(aminocarbonyl)-2-methylpropyl)-1-(5-fluoropentyl)-
Q27270338
PD047070
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]